Target intelligence / Profile preview

Iron (null)

Target
null
Molecular classification
Other
01

Overview

Iron is a chemical element (symbol Fe) essential for life, required as a cofactor in proteins involved in oxygen transport, mitochondrial electron transfer, DNA synthesis, and cell cycle regulation. Iron is not a molecular "receptor" or "target" but is implicated as a central component or cofactor in numerous proteins that serve as therapeutic targets, such as those regulating iron homeostasis, redox balance, and ferroptosis. Iron dysregulation is involved in many diseases, and both iron chelators and iron supplements are clinically used drugs for managing iron overload and deficiency, respectively. Iron modulation (e.g., through ferroptosis) is being explored as a therapeutic approach in cancer and neurodegenerative disease[3][4][5][6][7]. Additional context: - Ferroptosis is an iron-dependent form of regulated cell death characterized by lipid peroxidation, and therapeutic efforts seek to either induce (as in cancer) or inhibit (as in neurodegeneration) ferroptosis by targeting iron metabolism[4][5][6][7]. - Although many drugs interact with iron, in most cases they do so by chelating or supplementing iron, rather than specifically binding to a single iron target protein or receptor[3][5][6].

Other names
FeFerrum
02

Mechanism of action

Chelation of iron to reduce its bioavailability and prevent toxic overload[3][5][6] Supplementation to correct deficiency (iron salts, intravenous iron)[3][5] Modulation of ferroptosis sensitivity or resistance[4][5][7]

03

Biological functions

Oxygen transport (via hemoglobin/myoglobin)Electron transfer (in cytochromes)DNA synthesisCell growthSignal transduction (as a cofactor)Regulation of cell death (ferroptosis)
04

Disease associations

AnemiaCancerNeurodegenerative diseaseInfectionCardiovascular diseaseInflammationOther
05

Safety considerations

Iron overload toxicity (hemochromatosis, organ damage)[3][5]Hypersensitivity reactions to iron infusionsOxidative stress and tissue damageRisk of exacerbating infections (bacteria utilize iron)Anemia if depleted
06

Interacting drugs

Deferoxamine

9 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturationSerum ironTotal iron-binding capacity (TIBC)HepcidinLabile plasma iron

Beyond the preview

Go deeper on Iron (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call